FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES

MDR report key: 11096504 · Received December 30, 2020

Report

Report Number
9617032-2020-01081
Event Type
Malfunction
Date Received
December 30, 2020
Date of Event
December 7, 2020
Report Date
February 27, 2024
Manufacturer
BECTON, DICKINSON AND COMPANY (BD)
Product Code
JKA
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D.10. DEVICE AVAILABLE FOR EVAL?: YES D.10. RETURNED TO MANUFACTURER ON: 1/4/2021 H.6. INVESTIGATION: BD RECEIVED 10 SAMPLES FROM THE CUSTOMER FOR INVESTIGATION. ALL SAMPLES WERE EVALUATED BY FUNCTIONAL TESTING AND THE INDICATED FAILURE MODE FOR OVERFILL WITH THE INCIDENT LOT WAS NOT OBSERVED AS ALL PRODUCT SPECIFICATIONS WERE MET. THE FILL-LINE ON THESE TUBES IS A GUIDE TO THE MINIMUM FILL, SO THE DRAW SHOULD BE WELL ABOVE THE LINE UNTIL APPROACHING THE EXPIRY DATE. BASED ON A REVIEW OF THE DEVICE HISTORY RECORD FOR THE INCIDENT LOT, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET. THERE WERE NO RELATED QUALITY ISSUES DURING MANUFACTURING OF THE PRODUCT. BD WAS NOT ABLE TO IDENTIFIED A ROOT CAUSE FOR THE INDICATED FAILURE MODE. SEE H.10.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED: H6. MEDICAL DEVICE PROBLEM CODE: A140302 - OVERFILL COMPONENT CODE: G04134 - TUBE TYPE OF INVESTIGATION: B02 - TESTING OF DEVICE FROM SAME LOT/BATCH RETAINED BY MANUFACTURER B03 - TESTING OF DEVICE FROM SAME LOT/BATCH RETURNED FROM USER B11 - HISTORICAL DATA ANALYSIS B14 - ANALYSIS OF PRODUCTION RECORDS B15 - ANALYSIS OF DATA PROVIDED BY USER/THIRD PARTY INVESTIGATION FINDINGS: C19 - NO DEVICE PROBLEM FOUND INVESTIGATION CONCLUSION: D14 - NO PROBLEM DETECTED H6. INVESTIGATION SUMMARY: BD RECEIVED 10 SAMPLES AND 1 PHOTOGRAPH FROM THE CUSTOMER IN SUPPORT OF THIS COMPLAINT. EVALUATION OF THE PHOTOGRAPH INDICATES TUBES IN A HORIZONTAL POSITION, WHICH DOES NOT ALLOW TO SEE HOW MUCH BLOOD IS INSIDE THE TUBE. 10 RETURNED AND 20 RETAINED SAMPLES WERE DRAW TESTED. FROM THIS TESTING, IT WAS DETERMINED THAT ALL 30 TUBES DREW WITHIN SPECIFICATION. BD WAS UNABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE MODE BASED ON THE RETURNED AND RETAINED SAMPLES TEST RESULTS AND PHOTOGRAPH. THE FILL-LINE ON THESE TUBES IS A GUIDE TO THE MINIMUM FILL, SO THE DRAW SHOULD BE WELL ABOVE THE LINE UNTIL APPROACHING THE EXPIRY DATE. THE DEVICE HISTORY RECORDS WERE REVIEWED WITH NO ISSUES BEING IDENTIFIED. THERE WERE NO RELATED QUALITY NOTIFICATIONS. ALL PROCESSES AND FINAL INSPECTIONS COMPLY WITH SPECIFICATION REQUIREMENTS. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITIONS WILL CONTINUE TO BE TRACKED AND TRENDED. INFORMATION WILL BE CAPTURED ON TREND REPORTS AND MONITORED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR THE IDENTIFICATION OF EMERGING TRENDS. H3 OTHER TEXT : SEE H10.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: BD RECEIVED 10 SAMPLES AND 2 PHOTOGRAPHS FROM THE CUSTOMER IN SUPPORT OF THIS COMPLAINT. EVALUATION OF THE PHOTOGRAPHS INDICATES AN ACCEPTABLE DRAW VOLUME IN THE TUBE. A COPY OF BDS CITRATE TUBE DRAW VOLUME GUIDE IS PROVIDED TO THE CUSTOMER TO SHOW THE POSITION OF ACCEPTABLE FILL ON THE TUBE. ALTHOUGH THERE IS A SMALL VARIATION APPARENT IN THE DRAW VOLUMES, THESE DIFFERENCES FALL WITHIN THE EFFECTIVE RANGE OF THE TUBE. 10 RETURNED AND 20 RETAINED SAMPLES WERE DRAW TESTED. FROM THIS TESTING, IT WAS DETERMINED THAT ALL 30 TUBES DREW WITHIN SPECIFICATION. BD WAS UNABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE MODE BASED ON THE RETURNED AND RETAINED SAMPLES TEST RESULTS AND PHOTOGRAPHS ATTACHED. THE FILL-LINE ON THESE TUBES IS A GUIDE TO THE MINIMUM FILL, SO THE DRAW SHOULD BE WELL ABOVE THE LINE UNTIL APPROACHING THE EXPIRY DATE. THE DEVICE HISTORY RECORDS WERE REVIEWED WITH NO ISSUES BEING IDENTIFIED. THERE WERE NO RELATED QUALITY NOTIFICATIONS. ALL PROCESSES AND FINAL INSPECTIONS COMPLY WITH SPECIFICATION REQUIREMENTS. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITIONS WILL CONTINUE TO BE TRACKED AND TRENDED. INFORMATION WILL BE CAPTURED ON TREND REPORTS AND MONITORED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR THE IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES IN CLINICAL STUDY IT WAS DISCOVERED THAT THE TUBES ARE OVER FILLING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM GERMAN TO ENGLISH: CLINICAL STUDY SITE NOTICING HIGH VARIABILITY IN FILL VOLUME OF CITRATE TUBES, LATEST LOT PERCEIVED AS OVERFILLED; PT RESULTS VARIABILITY FOR ONE PATIENT WITH DIFFERENT TUBE LOTS.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES IN CLINICAL STUDY IT WAS DISCOVERED THAT THE TUBES ARE OVER FILLING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM GERMAN TO ENGLISH: CLINICAL STUDY SITE NOTICING HIGH VARIABILITY IN FILL VOLUME OF CITRATE TUBES, LATEST LOT PERCEIVED AS OVERFILLED; PT RESULTS VARIABILITY FOR ONE PATIENT WITH DIFFERENT TUBE LOTS.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES IN CLINICAL STUDY IT WAS DISCOVERED THAT THE TUBES ARE OVER FILLING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM GERMAN TO ENGLISH: CLINICAL STUDY SITE NOTICING HIGH VARIABILITY IN FILL VOLUME OF CITRATE TUBES, LATEST LOT PERCEIVED AS OVERFILLED; PT RESULTS VARIABILITY FOR ONE PATIENT WITH DIFFERENT TUBE LOTS.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES IN CLINICAL STUDY IT WAS DISCOVERED THAT THE TUBES ARE OVER FILLING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM (B)(6) TO ENGLISH: CLINICAL STUDY SITE NOTICING HIGH VARIABILITY IN FILL VOLUME OF CITRATE TUBES, LATEST LOT PERCEIVED AS OVERFILLED; PT RESULTS VARIABILITY FOR ONE PATIENT WITH DIFFERENT TUBE LOTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1563748 BD VACUTAINER® 9NC 0.129M PLUS BLOOD COLLECTION TUBES BLOOD SPECIMEN COLLECTION DEVICE JKA BECTON, DICKINSON AND COMPANY (BD) 0240225

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown